Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(21)00557-0
PubMed Identifier: 34919831
Publication URI: http://europepmc.org/abstract/MED/34919831
Type: Journal Article/Review
Volume: 22
Parent Publication: The Lancet. Infectious diseases
Issue: 4
ISSN: 1473-3099